Orthofix International | 销售成本

金融业

USD

USD 832.61M

现金及等价物

USD 62.86M

USD 253.61M

USD 394.17M

USD 159.85M

USD 137.24M

股息收益率

0

USD -18.9M

USD 7.73M

1.09K

EPS每股收益

USD -0.76

股本和储备

USD 442.49M

USD 545.89M

债务利息支出

5.2M

USD 157.22M

USD 500.1M

USD -126M

USD 10.89M

USD -84.62M

普通股股本

USD 3.82M

35.43

USD -123.88M

USD 799.49M

销售和管理费用

USD 112.22M

USD 174.04M

贸易债权人

USD 50.46M

应收帐款人

USD 124.85M

	销售成本	更改		日
Accuray	USD 116.17M		14.63M	2024-12
AngioDynamics	USD 33.15M		208K	2025-02
Artivion	USD 34.77M		75K	2024-09
AtriCure	USD 35.16M		2.23M	2025-12
Dexcom	USD 466.9M		11M	2025-12
EDAP TMS	EUR 7.91M		1.31M	2025-09
Globus Medical	USD 290.47M		8.09M	2025-12
Hologic	USD 463.7M		5.1M	2025-12
Inogen	USD 39.59M		1.27M	2024-09
Insulet	USD 215.2M		19M	2025-12
Integra LifeSciences	USD 193.44M		1.62M	2025-12
J&J	USD 7.97B		689M	2025-12
Medtronic	USD 3.61B		83M	2025-12
Mesa Laboratories	USD 21.92M		1.78M	2024-09
Orthofix International	USD 253.61M		192.05M	2024-12
Smith & Nephew	USD 870M		17M	2025-12
STAAR Surgical	USD 16.86M		5.34M	2025-09
Stryker	USD 2.69B		373M	2025-12
Surmodics	USD 33.03M		24.58M	2024-09
Tandem Diabetes Care	USD 122.92M		7.96M	2025-12
Teleflex	USD 261.54M		199.84M	2025-12
Veracyte	USD 39.28M		1.93M	2025-12
Zimmer Biomet Holdings	USD 970.1M		234.3M	2025-12

Orthofix International 销售成本 - 当前值，历史数据，预测，统计，图表和经济日历 - Mar 2026.